Depression screening predicts subsequent disability progression in people with primary progressive multiple sclerosis.

In stable MS patients, stopping Ocrevus does not seem to increase the risk of disease activity or disability progression for ...

Decreases in daytime activity among adults with MS, indicated via accelerometers worn on their wrists, indicated later ...

Reduced daytime physical activity, as measured with wearable trackers, is tied to increased risk for multiple sclerosis progression and brain atrophy, new research shows.

Fred D. Lublin, MD, discusses evolving concepts in MS, including earlier high-efficacy therapy, unrecognized progression, and ...

Data from fitness trackers showed not only who was at higher risk of disease progression, but whose brains might be in danger ...

Multiple sclerosis (MS) is a debilitating disease with few treatment options. But in a new clinical trial, scientists have tested a promising new therapy involving injections of stem cells, which ...

“Our data add and expand previous observations on silent progression in MS and are consistent with the view of the disease as a single continuum, in which RAW [relapse-associated worsening] and PIRA ...

A genome-wide association study (GWAS) including more than 22,000 people with multiple sclerosis (MS) has uncovered the first genetic variant associated with faster progression of the autoimmune ...

In people with primary progressive multiple sclerosis (MS), a new study has found no difference in the amount of time before disability worsened between people taking certain medications and those not ...

Disability progression independent of relapse activity (PIRA) -- sometimes referred to as silent progression -- is a key integrating concept in the contemporary view of multiple sclerosis (MS). "The ...

Grace Miller was a 24-year-old law school student when she was diagnosed with multiple sclerosis ...